CONTEXT: Participation in proficiency testing (PT) or external quality assessment (EQA) programs allows the assessment and comparison of test performance among different clinical laboratories and technologies. In addition to the approximately 2300 tests for individual genetic disorders, recent advances in technology have enabled the development of clinical tests that quickly and economically analyze the entire human genome. New PT/EQA approaches are needed to ensure the continued quality of these complex tests. OBJECTIVES: To review the availability and scope of PT/EQA for molecular genetic testing for inherited conditions in Europe, Australasia, and the United States; to evaluate the successes and demonstrated value of available PT/EQA programs; and to examine the challenges to the provision of comprehensive PT/EQA posed by new laboratory practices and methodologies. DATA SOURCES: The available literature on this topic was reviewed and supplemented with personal experiences of several PT/EQA providers. CONCLUSIONS: Proficiency testing/EQA schemes are available for common genetic disorders tested in many clinical laboratories but are not available for most genetic tests offered by only one or a few laboratories. Provision of broad, method-based PT schemes, such as DNA sequencing, would allow assessment of many tests for which formal PT is not currently available. Participation in PT/EQA improves the quality of testing by identifying inaccuracies that laboratories can trace to errors in their testing processes. Areas of research and development to ensure that PT/EQA programs can meet the needs of new and evolving genetic tests and technologies are identified and discussed.
CONTEXT: Participation in proficiency testing (PT) or external quality assessment (EQA) programs allows the assessment and comparison of test performance among different clinical laboratories and technologies. In addition to the approximately 2300 tests for individual genetic disorders, recent advances in technology have enabled the development of clinical tests that quickly and economically analyze the entire human genome. New PT/EQA approaches are needed to ensure the continued quality of these complex tests. OBJECTIVES: To review the availability and scope of PT/EQA for molecular genetic testing for inherited conditions in Europe, Australasia, and the United States; to evaluate the successes and demonstrated value of available PT/EQA programs; and to examine the challenges to the provision of comprehensive PT/EQA posed by new laboratory practices and methodologies. DATA SOURCES: The available literature on this topic was reviewed and supplemented with personal experiences of several PT/EQA providers. CONCLUSIONS: Proficiency testing/EQA schemes are available for common genetic disorders tested in many clinical laboratories but are not available for most genetic tests offered by only one or a few laboratories. Provision of broad, method-based PT schemes, such as DNA sequencing, would allow assessment of many tests for which formal PT is not currently available. Participation in PT/EQA improves the quality of testing by identifying inaccuracies that laboratories can trace to errors in their testing processes. Areas of research and development to ensure that PT/EQA programs can meet the needs of new and evolving genetic tests and technologies are identified and discussed.
Authors: Parviz Ahmad-Nejad; Alexandra Dorn-Beineke; Ulrike Pfeiffer; Joachim Brade; Wolf-Jochen Geilenkeuser; Simon Ramsden; Mario Pazzagli; Michael Neumaier Journal: Clin Chem Date: 2006-01-26 Impact factor: 8.327
Authors: Claudio Orlando; Paolo Verderio; Ronald Maatman; Jan Danneberg; Simon Ramsden; Michael Neumaier; Domenica Taruscio; Vincenzo Falbo; Robert Jansen; Claudia Casini-Raggi; Francesca Malentacchi; Ettore Marubini; Sara Pizzamiglio; Kris Vernelen; Jean-Claude Libeer; Vladimir Palicka; Mario Pazzagli Journal: Clin Chem Date: 2007-07 Impact factor: 8.327
Authors: Simon C Ramsden; Zandra Deans; David O Robinson; Roger Mountford; Erik A Sistermans; Wayne W Grody; Shirley McQuaid; Simon J Patton; Susan A R Stenhouse Journal: Genet Test Date: 2006
Authors: Arthur R Brothman; Michelle M Dolan; Barbara K Goodman; Jonathan P Park; Diane L Persons; Debra F Saxe; James H Tepperberg; Karen D Tsuchiya; Daniel L Van Dyke; Kathleen S Wilson; Daynna J Wolff; Karl S Theil Journal: Genet Med Date: 2011-09 Impact factor: 8.822
Authors: Antonia R Sepulveda; Stanley R Hamilton; Carmen J Allegra; Wayne Grody; Allison M Cushman-Vokoun; William K Funkhouser; Scott E Kopetz; Christopher Lieu; Noralane M Lindor; Bruce D Minsky; Federico A Monzon; Daniel J Sargent; Veena M Singh; Joseph Willis; Jennifer Clark; Carol Colasacco; R Bryan Rumble; Robyn Temple-Smolkin; Christina B Ventura; Jan A Nowak Journal: J Mol Diagn Date: 2017-02-06 Impact factor: 5.568
Authors: Lawrence J Jennings; Maria E Arcila; Christopher Corless; Suzanne Kamel-Reid; Ira M Lubin; John Pfeifer; Robyn L Temple-Smolkin; Karl V Voelkerding; Marina N Nikiforova Journal: J Mol Diagn Date: 2017-03-21 Impact factor: 5.568
Authors: Antonia R Sepulveda; Stanley R Hamilton; Carmen J Allegra; Wayne Grody; Allison M Cushman-Vokoun; William K Funkhouser; Scott E Kopetz; Christopher Lieu; Noralane M Lindor; Bruce D Minsky; Federico A Monzon; Daniel J Sargent; Veena M Singh; Joseph Willis; Jennifer Clark; Carol Colasacco; R Bryan Rumble; Robyn Temple-Smolkin; Christina B Ventura; Jan A Nowak Journal: Am J Clin Pathol Date: 2017-02-03 Impact factor: 2.493
Authors: Jeroen R Dijkstra; Bastiaan B J Tops; Iris D Nagtegaal; J Han J M van Krieken; Marjolijn J L Ligtenberg Journal: Virchows Arch Date: 2015-06-06 Impact factor: 4.064
Authors: Joshua R Kapp; Tim Diss; James Spicer; Michael Gandy; Iris Schrijver; Lawrence J Jennings; Marilyn M Li; Gregory J Tsongalis; David Gonzalez de Castro; Julia A Bridge; Andrew Wallace; Joshua L Deignan; Sandra Hing; Rachel Butler; Eldo Verghese; Gary J Latham; Rifat A Hamoudi Journal: J Clin Pathol Date: 2014-11-27 Impact factor: 3.411
Authors: Palak G Patel; Shamini Selvarajah; Karl-Philippe Guérard; John M S Bartlett; Jacques Lapointe; David M Berman; John B A Okello; Paul C Park Journal: PLoS One Date: 2017-06-22 Impact factor: 3.240
Authors: Lisa V Kalman; Vivekananda Datta; Mickey Williams; Justin M Zook; Marc L Salit; Jin Yeong Han Journal: Ann Lab Med Date: 2016-11 Impact factor: 3.464